💡 In a world where medical breakthroughs dominate headlines, Cai Lei's story reminds us that true heroism often lies in perseverance. The ALS advocate and former tech executive continues to drive global research efforts despite knowing newly developed drug Rag-17 won't help his own condition.
Using eye-tracking technology to communicate, Cai recently told our team: "This isn't about me – it's about accelerating solutions for future generations." His Beijing-based foundation has trained over 2,000 families in care techniques this year alone 🌏.
🔬 While Rag-17 targets specific genetic mutations (which Cai lacks), his $3.8M research grants now support 14 international studies exploring alternative treatments. "Cai's approach is like crowdsourcing cures," says Dr. Priya Sharma, a Mumbai-based neurologist collaborating on three projects.
From virtual reality therapy trials to AI-powered symptom trackers, these initiatives reflect Cai's tech-forward vision. His next goal? Launching a global registry connecting ALS patients with compatible clinical trials by Q2 2026 📲.
👨👩👧👦 Beyond labs, the foundation's free online courses teach families everything from nutrition hacks to emotional support strategies. "We're building bridges between hospitals and living rooms," Cai shared via his communication device last week.
